Professional Documents
Culture Documents
The harmful outcome is usually indicated by some result such as morbidity, mortality,
alteration in body weight, levels of enzymes, loss of function, or as a pathological change
detected at the microscopic, macroscopic or physiological level. It may also be indicated
by symptoms reported by a patient. Adverse effects may cause a reversible or irreversible
change, including an increase or decrease in the susceptibility of the individual to other
chemicals, foods, or procedures (e.g. drug interaction).
In clinical trials, a distinction is made between Adverse Events (AEs) and Serious
Adverse Events (SAEs). Generally, any event which causes death, permanent damage,
birth defects, or requires hospitalization is considered an SAE. [1] The results of these
trials are often included in the labeling of the medication to provide information both for
patients and the prescribing physicians.
Contents
[hide]
• 1 Reporting systems
o 1.1 UK
o 1.2 USA
o 1.3 Australia
• 2 Adverse effects of medical procedures
• 3 Adverse effects of drugs
• 4 Controversies
• 5 Limitations of adverse effects reporting
• 6 Examples of adverse effects associated with specific medications
• 7 See also
• 8 References
• 9 External links
[edit] UK
The Yellow Card Scheme is a UK initiative run by the Medicines and Healthcare
products Regulatory Agency (MHRA) and the Commission on Human Medicines (CHM)
to gather information on adverse effects to medicines. This includes all licensed
medicines from medicines issued on prescription to medicines bought over the counter
from a supermarket. The Scheme also includes all herbal preparations and unlicensed
medicines found in cosmetic treatments. ADRs can be reported by a number of healthcare
professionals including doctors, pharmacists and nurses, as well as patients.
For further information see the Yellow Card Scheme website, or find copies of the
Yellow Card in the appedices of a BNF.
To read reports from the UK Yellow Card Scheme you can download here.
[edit] USA
In the USA several reporting systems have been built, such as the Vaccine Adverse Event
Reporting System (VAERS), the Manufacturer and User Facility Device Experience
Database (MAUDE) and the Special Nutritionals Adverse Event Monitoring System.
MedWatch is the main reporting center, operated by the Food and Drug Administration.
[edit] Australia
Vaccination may have adverse effects, due to the nature of its biological preparation
(sometimes using attenuated pathogens and toxins). Common adverse effects may be
fever, malaise and local reactions in the vaccination site, such as eczema vaccinatum, a
severe, sometimes fatal complication which may result in persons who have eczema or
atopic dermatitis.
Diagnostic procedures may also have adverse effects, depending much on whether they
are invasive, non-invasive or minimally invasive. For example, allergic reactions to x-ray
contrasting material often occur, a colonoscopy may cause the perforation of the intestine
wall, etc.
Adverse effects can occur as a collateral or side effect of many interventions, but they are
particularly important in pharmacology, due to its wider, and sometimes uncontrollable,
use by way of self-medication. Thus, responsible drug use becomes an important issue
here.
Adverse effects, like intended effects of drugs, are a function of dosage or drug levels at
the target organs, so they may be avoided or decreased by means of careful and precise
pharmacokinetics (the change of drug levels in the organism in function of time after
administration).
Adverse effects may also be caused by drug interaction, i.e., when physicians fail to
check for all medicaments a patient is taking and prescribe new ones which interact
agonistically or antagonistically (potentiate or decrease the intended therapeutic effect).
Significant morbidity and mortality is caused around the world because of this. Drug-
drug and food-drug interactions may occur, and even so-called "natural drugs" used in
alternative medicine may have dangerous adverse effects. For example, extracts of St.
John's wort (Hypericum perforatum), a phytotherapic used for treating mild depression
are known to cause an increase in the cytochrome P450 enzymes responsible for the
metabolism and elimination of many drugs, so that patients taking it are likely to
experience a reduction in blood levels of drugs that they are taking for other purposes,
such as cancer chemotherapeutic drugs, protease inhibitors for HIV and hormonal
contraceptives.
The scientific field of activity associated with drug safety is increasingly government-
regulated and is of major concern for the public as well as to drug manufacturers. The
distinction between adverse and non-adverse effects is a major undertaking when a new
drug is developed and tested before marketing it. This is done in toxicity studies to
determine the non-adverse effect level (NOAEL). These studies are used to define the
dosage to be used in human testing (phase I) as well as to calculate the maximum
admissible daily intake. Imperfections in clinical trials, such as insufficient number of
patients or short duration, sometimes lead to public health disasters such as those of
fenfluramine (the so-called fen-phen episode), thalidomide and, more recently, of
cerivastatin (Baycol, Lipobay) and rofecoxib (Vioxx), where drastic adverse effects were
observed, like teratogenesis, pulmonary hypertension, stroke, heart disease, neuropathy,
etc., and a significant number of deaths, causing the forced or voluntary withdrawal of
the drug from the market.
Most drugs have a large list of non-severe or mild adverse effects which do not rule out
the interruption of usage. These effects have widely variable incidence, according to
individual sensitivity. They comprise nausea, dizziness, diarrhea, malaise, vomit,
headache, dermatitis, dry mouth, etc.
[edit] Controversies
Sometimes, putative medical adverse effects are regarded as controversial and generate
heated discussions in society and lawsuits against drug manufacturers. One example is
the recent controversy as to whether autism was linked to the MMR vaccine (or by
thimerosal, a mercury-based preservative used in some vaccines). No link has been found
in several large studies and no change in the rate of autism has occurred when thimerisal
was removed from vaccines a decade ago in Canada and Europe.
Another instance is the potential adverse effects of silicone breast implants, which lead to
hundreds of thousands of litigations against manufacturers of gel-based implants, due to
allegations of damage to the immune system which have not yet been conclusively
proven.
Due to the exceedingly high impact on public health of widely used medications, such as
hormonal contraception and hormone replacement therapy, which may affect millions of
users, even marginal probabilities of adverse effects of a severe nature, such as breast
cancer, have led to public outcry and changes in medical therapy, although its benefits
largely surpassed the statistical risks.
As a result, routine adverse effects reporting may often not include long-term and subtle
effects that may ultimately be attributed to a therapy.
Part of the difficulty is identifying the source of a complaint. A headache in a patient
taking medication for influenza may be the underlying disease and may be an adverse
effect. In patients with end-stage cancer, death is a very likely outcome and whether the
drug is the cause or a bystander is often difficult to discern.